These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10175029)

  • 21. Risky business: Healthcare IS stocks have seen better days. Are they coming back?
    Elliott J
    Healthc Inform; 1999 Jun; 16(6):105-6, 108. PubMed ID: 10557630
    [No Abstract]   [Full Text] [Related]  

  • 22. This fever chart may turn up. Healthcare stocks, bonds may have bright future despite market sell-off.
    Kirchheimer B; Jaklevic MC
    Mod Healthc; 2001 Sep; 31(39):4-5. PubMed ID: 11586617
    [No Abstract]   [Full Text] [Related]  

  • 23. Big deal for HBO & Co. Company to pay $1 billion in stock for Access Health.
    Morrissey J
    Mod Healthc; 1998 Oct; 28(40):38. PubMed ID: 10185601
    [No Abstract]   [Full Text] [Related]  

  • 24. Past their prime? Healthcare borrowers not immune from roiling credit market, but effects more subtle.
    Becker C
    Mod Healthc; 2007 Oct; 37(39):36, 38. PubMed ID: 17958221
    [No Abstract]   [Full Text] [Related]  

  • 25. Going strong, going public. Despite spate of chronic problems and calls for reform, healthcare initial public offerings demonstrate fiscal health.
    Zigmond J
    Mod Healthc; 2007 Dec 24-31; 37(51):6-7, 16, 1. PubMed ID: 18220122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The decade of the '90s. Poor use of IT investment contributes to the growing healthcare crisis.
    Dorenfest S
    Healthc Inform; 2000 Aug; 17(8):64-7. PubMed ID: 11185141
    [No Abstract]   [Full Text] [Related]  

  • 27. Leading indicators.
    Kirchheimer B
    Mod Healthc; 2000 May; 30(20):36. PubMed ID: 11067150
    [No Abstract]   [Full Text] [Related]  

  • 28. S&P's prognosis: managed care will gain in health.
    Pallarito K
    Mod Healthc; 1998 Sep; 28(37):12. PubMed ID: 10183087
    [No Abstract]   [Full Text] [Related]  

  • 29. High on health care.
    Serb C
    Hosp Health Netw; 1999 Feb; 73(2):28. PubMed ID: 10081450
    [No Abstract]   [Full Text] [Related]  

  • 30. There she is, your ideal.
    Stern L
    Newsweek; 2001 Aug; 138(9):60-1. PubMed ID: 11534250
    [No Abstract]   [Full Text] [Related]  

  • 31. Boom vs. bust.
    Serb C
    Hosp Health Netw; 1999 Mar; 73(3):58-9, 2. PubMed ID: 10191735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On a smaller scale. Boutique investment firms ready to feed a hungry market.
    Kirchheimer B
    Mod Healthc; 2001 Jan; 31(2):60, 63. PubMed ID: 11418964
    [No Abstract]   [Full Text] [Related]  

  • 33. Controlled-risk foreign investment strategy can boost yields.
    Simms RA
    Healthc Financ Manage; 2000 Jun; 54(6):60-2. PubMed ID: 11010184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paper, paper everywhere.
    McCarthy R
    State Health Care Am; 2001; ():48-50. PubMed ID: 11521325
    [No Abstract]   [Full Text] [Related]  

  • 35. Health care software stocks bugged by Y2K.
    Siwicki B
    Health Data Manag; 1999 Jun; 7(6):66-8, 72, 74. PubMed ID: 10538215
    [No Abstract]   [Full Text] [Related]  

  • 36. The challenging home care market.
    Sherter AL
    Health Data Manag; 1998 Nov; 6(11):78. PubMed ID: 10185898
    [No Abstract]   [Full Text] [Related]  

  • 37. Healthcare stock prices up 10%.
    Lutz S
    Mod Healthc; 1995 Apr; 25(15):30. PubMed ID: 10141505
    [No Abstract]   [Full Text] [Related]  

  • 38. The year of the bull (or bear)? Experts predict that in 2008, the healthcare industry's major issues will largely be determined by the nation's economy.
    Becker C; Galloro V; Vesely R; Evans M; Zigmond J; Blesch G; Conn J; DerGurahian J; Rhen S; Robeznieks A
    Mod Healthc; 2008 Jan; 38(1):22-3, 26-9. PubMed ID: 18271197
    [No Abstract]   [Full Text] [Related]  

  • 39. Strategic surgery.
    Feorene BT; Kanaan CR
    Hosp Health Netw; 1999 Feb; 73(2):68, 70. PubMed ID: 10081458
    [No Abstract]   [Full Text] [Related]  

  • 40. Device deals dominate. DJO, Biomet buyouts gain steam as Abbott's fizzles.
    Rhea S
    Mod Healthc; 2007 Jul; 37(29):17. PubMed ID: 17844789
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.